News

M3GAN 2.0 is taking a leap from horror and embracing another genre that the Terminator franchise pioneered decades ago.
New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open label extension ...